_Therapeutically Suggestive Names._--Articles bearing therapeutically suggestive names will not be accepted for New and Nonofficial Remedies, first, because they are likely to lead physicians into prescribing names instead of remedies, and second, because they tend to encourage unwarranted self-medication by the laity. Even if the name is at first apparently meaningless to the public, its meaning will soon be understood because patients soon learn the technical names applied to their diseases and symptoms. The prohibition against therapeutically suggestive names is not applied to serums, vaccines and antitoxins, because the accepted nomenclature of the specific organisms used in their preparation makes this unavoidable and because self-medication with them is improbable. Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc. _Protection._--This information is important as a means of determining the legal status of medicinal articles and as an aid to their ready recognition in current publications. Explanation of Rule 10: Unscientific and Useless Articles _Unscientific Compounds._--The use of articles which are unessential modifications of official or established nonproprietary articles is unscientific and serves no useful purpose. The Council will not accept products which are scientifically unsound and which, therefore, must be considered useless or inimical to the best interest of the medical profession and the public. This class includes compounds or mixtures containing an excessive number of active ingredients; those compounds or mixtures the components of which are of no probable assistance to one another, and those articles which are of no therapeutic value. _Unessential Modifications of Official Substances._--The subterfuge of obtaining proprietary rights over an official or established nonproprietary product, by introducing unessential modifications, also tends to confusion and abuses, and such articles will not be admitted by the Council. Essential and important modifications, however, will receive recognition. (The Council interprets the term “established nonproprietary product” as applying to a preparation of any formula which has been published through any recognized or reasonably accessible channel of publication, prior to its appropriation or modification by a manufacturer.) Duplicates of biologic products accepted under the name of the manufacturers will not be accepted under the names of the distributors. THE COUNCIL ON PHARMACY AND CHEMISTRY, PRESENT AND FUTURE[A] W. A. Puckner, Phar.D. Secretary, Council on Pharmacy and Chemistry [A] Read before the Chicago Medical Society, March 26, 1919.